Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 4 5 6 Next >

Johnson & Johnson to Host Enterprise Business Review

October 27, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026

October 22, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half

October 20, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026

October 13, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson reports Q3 2026 results, raises 2026 guidance

October 13, 2026

From Johnson & Johnson

Via Business Wire

New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause

October 01, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses

September 10, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit

September 02, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

August 31, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

August 10, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

August 04, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

August 04, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

July 29, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset

July 29, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

July 27, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

July 22, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award

July 16, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

July 15, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

July 15, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

July 08, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

June 15, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients

June 11, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform

June 08, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

May 27, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter

May 12, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 11, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System

May 05, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations

April 30, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference

April 27, 2026

From Johnson & Johnson

Via Business Wire

Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

April 21, 2026

From Johnson & Johnson

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.